Financiere de Tubize (CHIX:TUBB) ROC (Joel Greenblatt) %: -312,533.33% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:TUBB Financiere de Tubize SA CHIX:TUBB
43 GF Score
Price €235.20
! 1 Warning Sign
View Full Analysis

What is Financiere de Tubize ROC (Joel Greenblatt) %?

Financiere de Tubize CHIX:TUBB 43 ROC (Joel Greenblatt) % is -312,533.33% as of Dec. 2025. GuruFocus rates CHIX:TUBB with a GF Score™ of 43/100. The stock has 1 warning sign investors should review. Among 1,323 Biotechnology companies, Financiere de Tubize ranks better than 99.92% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Financiere de Tubize's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -312,533.33%.

The historical rank and industry rank for Financiere de Tubize's ROC (Joel Greenblatt) % or its related term are showing as below:

CHIX:TUBb' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4630050   Med: 5446591.67   Max: 6263133.33
Current: 5636820

During the past 13 years, Financiere de Tubize's highest ROC (Joel Greenblatt) % was 6263133.33%. The lowest was 4630050.00%. And the median was 5446591.67%.

CHIX:TUBb's ROC (Joel Greenblatt) % is ranked better than
99.92% of 1323 companies
in the Biotechnology industry
Industry Median: -297.52 vs CHIX:TUBb: 5636820.00

Financiere de Tubize's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Financiere de Tubize  (CHIX:TUBb) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Financiere de Tubize ROC (Joel Greenblatt) % Related Terms


Financiere de Tubize ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Financiere de Tubize's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Financiere de Tubize ROC (Joel Greenblatt) % Chart

Financiere de Tubize Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 4,630,050.00 6,263,133.33

Financiere de Tubize Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 6,305,266.67 -158,160.00 9,629,100.00 -312,533.33

CHIX:TUBB vs VRTX, REGN, ALNY: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, Financiere de Tubize's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Financiere de Tubize ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's ROC (Joel Greenblatt) % falls into.


CHIX:TUBB
43GF Score
Financiere de Tubize SA CHIX:TUBB
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Financiere de Tubize ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.00099999999999989) - (0.25 + 0 + 0.117)
=-0.366

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.298 + 0 + 48.281)
=-48.579

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Financiere de Tubize for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-4.688/( ( (0.002 + max(-0.366, 0)) + (0.001 + max(-48.579, 0)) )/ 2 )
=-4.688/( ( 0.002 + 0.001 )/ 2 )
=-4.688/0.0015
=-312,533.33 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -312,533.33% mean?
Financiere de Tubize (CHIX:TUBB) has a ROC (Joel Greenblatt) % of -312,533.33% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Financiere de Tubize and its competitors. Over the past decade, Financiere de Tubize's ROC (Joel Greenblatt) % has ranged from 4,630,050.00 to 6,263,133.33. According to the industry distribution chart, Financiere de Tubize ranks #1 out of 1323 companies in the Biotechnology industry, placing it in the top 0.099999999999994%.
Is Financiere de Tubize's ROC (Joel Greenblatt) % too high?
Financiere de Tubize's current ROC (Joel Greenblatt) % is -312,533.33%. Over the past 10 years, this metric has ranged from a low of 4,630,050.00 to a high of 6,263,133.33. Based on the distribution chart, Financiere de Tubize ranks #1 out of 1323 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Financiere de Tubize has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Financiere de Tubize's ROC (Joel Greenblatt) % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Financiere de Tubize ranks #1 out of 1323 companies for ROC (Joel Greenblatt) %. This places Financiere de Tubize in the top 0% of its industry — outperforming the majority of peers. Historically, Financiere de Tubize's own ROC (Joel Greenblatt) % has ranged from 4,630,050.00 to 6,263,133.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Financiere de Tubize and its competitors. Financiere de Tubize's current ROC (Joel Greenblatt) % is -312,533.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Financiere de Tubize stock overvalued right now?
Financiere de Tubize (CHIX:TUBB) has a current ROC (Joel Greenblatt) % of -312,533.33%. The current ROC (Joel Greenblatt) % is -312,533.33%. Financiere de Tubize's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Financiere de Tubize (CHIX:TUBB), the current ROC (Joel Greenblatt) % is -312,533.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Financiere de Tubize Business Description

Address Allee de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
43GF Score

Get the complete analysis for CHIX:TUBB

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€235.20
Price